Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section

Next Previous
Trial Profile

Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atropine (Primary) ; Neostigmine (Primary) ; Rocuronium bromide (Primary) ; Sugammadex (Primary) ; Suxamethonium chloride (Primary)
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Acronyms RocSugIO

Most Recent Events

  • 17 Mar 2016 New trial record
  • 11 Mar 2016 Primary endpoint has been met. (time needed to tracheal intubation), as per results published in the Anesthesia and Analgesia.
  • 11 Mar 2016 Results published in the Anesthesia and Analgesia

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top